Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajmohan Murali

Showing results (121-130 of 203) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2013
The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patientsAugustinus P T van der Ploeg, Alexander C J van Akkooi, Lauren E Haydu, et al.
The Journal of Investigative Dermatology|April 10, 2016
Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation SignatureJohannes van de Nes, Karsten Wrede, Adrian Ringelstein, et al.
Cell|December 10, 2013
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockadeVivek K Arora, Emily Schenkein, Rajmohan Murali, et al.
Histopathology|December 20, 2018
Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexaRajmohan Murali, Pier Selenica, David N Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 14, 2018
Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort StudyBrian Z Ring, Rajmohan Murali, Robert A Soslow, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Pigment Cell & Melanoma Research|December 9, 2009
High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanomaYasufumi Goto, Takaaki Arigami, Rajmohan Murali, et al.
The Journal of Investigative Dermatology|May 14, 2017
Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic TumorsJohannes A P van de Nes, Christian Koelsche, Marco Gessi, et al.
Annals of Surgical Oncology|January 4, 2008
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometryAlison Beavis, Michael Dawson, Philip Doble, et al.
Pageof 21

Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|June 28, 2015
Development of a risk stratification system to guide treatment for female germ cell tumorsJane L Meisel, Kaitlin M Woo, Nora Sudarsan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2013
The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patientsAugustinus P T van der Ploeg, Alexander C J van Akkooi, Lauren E Haydu, et al.
The Journal of Investigative Dermatology|April 10, 2016
Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation SignatureJohannes van de Nes, Karsten Wrede, Adrian Ringelstein, et al.
Cell|December 10, 2013
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockadeVivek K Arora, Emily Schenkein, Rajmohan Murali, et al.
Histopathology|December 20, 2018
Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexaRajmohan Murali, Pier Selenica, David N Brown, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 14, 2018
Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort StudyBrian Z Ring, Rajmohan Murali, Robert A Soslow, et al.
Histopathology|June 28, 2012
Lymphatic vessel density in primary melanomas predicts sentinel lymph node status and risk of metastasisRamin Shayan, Tara Karnezis, Rajmohan Murali, et al.
Pigment Cell & Melanoma Research|December 9, 2009
High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanomaYasufumi Goto, Takaaki Arigami, Rajmohan Murali, et al.
The Journal of Investigative Dermatology|May 14, 2017
Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic TumorsJohannes A P van de Nes, Christian Koelsche, Marco Gessi, et al.
Annals of Surgical Oncology|January 4, 2008
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometryAlison Beavis, Michael Dawson, Philip Doble, et al.
Pageof 21